| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 07, 2026 |
Adma Biologics Inc
ADMA
|
BUY |
$18.00
Est. +79%
|
$10.08 | $9.04 |
Pending
|
$8.95
-11.2%
|
| Nov 03, 2025 |
Abbvie Inc
ABBV
|
BUY |
$256.00
Est. +17%
|
$218.04 | $261.64 |
Precision Hit (±3%)
|
$261.07
+19.7%
|
| Oct 17, 2025 |
Abbvie Inc
ABBV
|
BUY |
$250.00
Est. +10%
|
$226.87 | $261.64 |
Target Met
|
$261.07
+15.1%
|
| Sep 22, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$75.00
Est. +22%
|
$61.36 | $86.74 |
Target Met
|
$81.80
+33.3%
|
| Feb 03, 2025 |
Abbvie Inc
ABBV
|
BUY |
$220.00
Est. +16%
|
$190.14 | $244.81 |
Target Met
|
$261.07
+37.3%
|
| Nov 13, 2024 |
Schrodinger Inc
SDGR
|
BUY |
$28.00
Est. +48%
|
$18.91 | $28.45 |
Precision Hit (±3%)
|
$16.88
-10.7%
|
| Nov 05, 2024 |
AbCellera Biologics Inc
ABCL
|
BUY |
$5.00
Est. +82%
|
$2.74 | $6.52 |
Target Met
|
$8.11
+196.0%
|
| Sep 18, 2024 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$83.00
Est. +36%
|
$61.23 | $99.50 |
Target Met
|
$86.03
+40.5%
|
| Sep 29, 2023 |
Abbvie Inc
ABBV
|
BUY |
$177.00
Est. +19%
|
$149.12 | $199.94 |
Target Met
|
$261.07
+75.1%
|
| Apr 26, 2022 |
Abbvie Inc
ABBV
|
BUY |
$174.00
Est. +10%
|
$157.72 | - | - |
$261.07
+65.5%
|
| Feb 25, 2022 |
Sage Therapeutics Inc
SAGE
|
BUY |
$48.00
Est. +31%
|
$36.65 | - | - |
$8.68
-76.3%
|
| Feb 11, 2022 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$175.00
Est. +16%
|
$150.76 | - | - |
$312.78
+107.5%
|
| Jan 18, 2022 |
Abbvie Inc
ABBV
|
BUY |
$153.00
Est. +12%
|
$136.78 | - | - |
$261.07
+90.9%
|